Is whole-body FDG-PET valuable for health screening? Against.

European journal of nuclear medicine and molecular imaging

Volumn 32, Issue 3, 2005, Pages 342-343

  Weckesser, Matthias ^a   Schober, Otmar ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CLINICAL PRACTICE; HUMAN; MASS SCREENING; METHODOLOGY; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; SCINTISCANNING; UTILIZATION REVIEW; WHOLE BODY COUNTING;

FLUORODEOXYGLUCOSE F18; HUMANS; MASS SCREENING; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES; RADIOPHARMACEUTICALS; WHOLE-BODY COUNTING;

EID: 24644440967     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1775-2     Document Type: Article

References (0)